Skip to content
Medical Health Aged Care

Pre-pregnancy risk factors are common amongst women of reproductive age

Monash University 2 mins read

Researchers want to improve the recording of pregnancy risk factors in GP medical records for their women patients after a Monash University-led audit found a concerning number were at risk. 

 

Published in BMJ Sexual & Reproductive Health, the audit of 10 Melbourne general practices found a significant number of women patients aged 18-44 had conditions that could complicate pregnancy.

 

This included a mental health condition (28 per cent), obesity (24 per cent), possibly using medication that could cause birth defects (17 per cent), smoking (14 per cent), asthma (13 per cent), high blood pressure (7 per cent), thyroid disease (6 per cent) and diabetes (5 per cent).

 

First author and Monash University SPHERE Centre for Research Excellence PhD candidate, Nishadi Withanage, said it was the first audit of its kind.

 

Ms Withanage said the results demonstrated a large burden of risk among women visiting GPs, and highlighted the potential of electronic medical records (EMRs) to identify those who could most benefit from preconception care.

 

“Preconception care refers to interventions provided before pregnancy that reduce adverse pregnancy outcomes and optimise maternal and child health,” she said.

 

“While Australian general practice is ideally placed to provide preconception care it is currently not routinely provided and there is no systematic way to identify women who may most benefit from preconception care in these settings.

 

Utilising electronic medical records to identify those most at risk and invite them to receive preconception care might be a way forward.”

 

Ms Withanage said documenting medical and lifestyle preconception health risk factors could help primary care providers identify and provide preconception care to women who may benefit.

 

She said while the study highlighted the potential for EMRs to be used to instigate preconception care, they were currently not used for this purpose.

 

“Initiatives to support and improve the quality of information recorded in EMRs are warranted,” she said. “We also recommend changes to the EMR software such as including a structured field for recording reproductive intent.” 

 

If EMRs are to be used to improve preconception care, GPs will need to maximise their use of existing structured fields and ensure data is regularly updated. They could prioritise recording information in structured fields instead of free text in clinical notes, for efficient retrieval during subsequent consultations.


“Involving receptionist staff and practice managers in providing feedback reports on preconception health data quality can enhance the completeness of the EMR,” Ms Withanage said.

 

“We do not anticipate that there will be any privacy issues. However, prior to implementing a system that instigates preconception care based on an EMR-generated risk profile, it is important to investigate acceptability towards this from both the providers’ and consumers’ perspectives.” 

 

Read more on Monash University’s thought leadership platform Lens

 

For media enquiries please contact:

 

Monash University

Cheryl Critchley – Media and Communications Manager (medical)
E:
cheryl.critchley@monash.edu

T: +61 (0) 477 571 442

 

For more Monash media stories, visit our news and events site 


For general media enquiries please contact:
Monash Media
E: 
media@monash.edu
T: +61 (0) 3 9903 4840

 

***ENDS***

 

More from this category

  • Medical Health Aged Care
  • 20/09/2024
  • 02:41
Neuraptive Therapeutics Inc.

Neuraptive Therapeutics Announces Presentation of Phase 2 Topline Interim Results for NTX-001 at the 2024 American Society for Surgery of the Hand (ASSH) Annual Meeting

– Interim 24-week data from the NEUROFUSE study highlights the safety and efficacy of NTX-001 for peripheral nerve injuries. CHESTERBROOK, Pa.–BUSINESS WIRE– Neuraptive Therapeutics…

  • Contains:
  • Medical Health Aged Care
  • 19/09/2024
  • 22:11
Takeda Pharmaceutical Company Limited

Takeda to Present Additional Clinical Trial Study Data Highlighting the Impact of Orexin Agonist TAK-861 on the Burden of Narcolepsy at Sleep Europe 2024

− Presentations Include New Data from the TAK-861-2001 Phase 2b Trial in Narcolepsy Type 1 Highlighting Impact on Daily Functioning Including Cognition and Sleep…

  • Contains:
  • Medical Health Aged Care
  • 19/09/2024
  • 13:18
Eastern Health

The generous legacy helping thousands of lives

Thanks to generous donations to the Eastern Health Foundation, Box Hill Hospital has received a new PET Scanner. The new PET Scanner will help thousands of people each year, to receive detailed images, crucial in diagnosing and staging various conditions, leading to more targeted and effective treatment. Through a dedicated fundraising campaign, the Eastern Health Foundation made the PET Scanner a reality. One of the biggest contributors to the cause was AmberGooding, who tragically passed from cancer in 2017. The PET Scanner will improve continuity of care and allowing medical professionals to track how patients are responding to therapies and…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.